Biomimetic vascular network and devices using the same

Patent metadata

Field	Value
Publication number	US-10327885-B2
Application number	US-201514615646-A
Country	US
Kind code	B2
Filing date	Feb 6, 2015
Priority date	Apr 12, 2007
Publication date	Jun 25, 2019
Grant date	Jun 25, 2019

Abstract

The invention provides method of fabricating a scaffold comprising a fluidic network, including the steps of: (a) generating an initial vascular layer for enclosing the chamber and providing fluid to the cells, the initial vascular layer having a network of channels for fluid; (b) translating the initial vascular layer into a model for fluid dynamics analysis; (c) analyzing the initial vascular layer based on desired parameters selected from the group consisting of a characteristic of a specific fluid, an input pressure, an output pressure, an overall flow rate and combinations thereof to determine sheer stress and velocity within the network of channels; (d) measuring the sheer stress and the velocity and comparing the obtained values to predetermined values; (e) determining if either of the shear stress or the velocity are greater than or less than the predetermined values, and (f) optionally modifying the initial vascular layer and repeating steps (b)-(e). The invention also provides compositions comprising a vascular layer for use in tissue lamina as well as a medical devices having a vascular layer and kits.

First claim

What is claimed is:

1. An artificial vascular layer comprising:
a substrate defining a network of channels arranged in a pattern having at least one input channel, at least one output channel, and a plurality of intermediate channels connecting the at least one input channel and the at least one output channel, each channel having a height defined by opposing sidewalls, a length, and a width defined by a bottom, wherein the intermediate channels undergo multiple branching and rejoining to form transition areas from channel to channel, wherein the transition area in at least one intermediate channel includes a first fillet on each opposing sidewall.

2. The artificial vasculature layer of claim 1 , wherein a first bottom of a first of the intermediate channels is on a different plane than a second bottom of a second of the intermediate channels so that a ramp is formed in the transition area between the first and the second bottom to reduce shear stress concentration, flow separation, stasis or turbulence.

3. The artificial vasculature layer of claim 2 , wherein the sidewall extends up from the bottom of each channel, and, in the transition area, at least a portion of the sidewalls is beveled to form an elongated fillet to reduce shear stress concentration, flow separation, stasis or turbulence.

4. The artificial vasculature layer of claim 1 , wherein the intermediate channels are formed by varying said height and width with respect to adjacent portions of the channels and the length of a smallest of the intermediate channels is formed based on the respective diameter whereby said smallest intermediate channel has a biomimetic length.

5. The artificial vasculature layer of claim 1 , wherein the intermediate channels undergo multiple branching and rejoining to form areas intermediate to the intermediate channels.

6. The artificial vasculature layer of claim 1 , wherein the intermediate channels undergo multiple branching and rejoining according to Murray's law.

7. The artificial vasculature layer of claim 1 , wherein:
the at least two intermediate channels form an area therebetween;
the area includes cells; and
a maximum distance between the at least two intermediate channels does not exceed a maximum diffusion distance of oxygen and nutrients for the cells.

8. An artificial vascular layer comprising:
a substrate defining a network of channels having at least one input channel and at least one output channel and a plurality of branching intermediate channels at least partially connecting the at least one input channel and the at least one output channel, each channel having a height, a length, and a width,
wherein at least one of the intermediate channels has a planar bottom extending between opposing planar side walls to form bottom corners and further comprising fillets in the bottom corners, and wherein the fillets are determined by an iterative computational fluid dynamics (CFD) analysis to minimize shear stress, low flow velocity and stagnation using a target shear stress, an inlet pressure, an outlet pressure, a resulting flow rate, and a velocity of fluid passing through the network.

9. The artificial vasculature layer of claim 8 , the length of at least one of the intermediate channels is formed based on the diameter of said at least one intermediate channel, whereby said at least one intermediate channel is a smallest intermediate channel and has a biomimetic length.

10. The artificial vasculature layer of claim 8 , further comprising a transition area at about an intersection between at least two of the channels having different dimensions, wherein the transition area is configured to reduce shear stress at the intersection.

11. The artificial vasculature layer of claim 10 , wherein the transition area comprises a ramp providing a transition from a bottom of a first of the at least two channels to a bottom of a second of the at least two channels, wherein the first of the at least two channels has a first height, and the second of the at least two channels has a second height, different from the first height.

12. The artificial vasculature layer of claim 10 , wherein the transition area comprises a fillet providing a transition from a bottom of a first of the at least two channels to a bottom of a second of the at least two channels, wherein the first of the at least two channels has a first height, and the second of the at least two channels has a second height, different from the first height.

13. A device comprising:
a first substrate defining a vasculature layer having at least one input channel, at least one output channel, and at least two intermediate channels at least partially connecting the at least one input channel and the at least one output channel, each channel having a height, a length, and a width, and a hydraulic diameter; and
transition areas between the channels,
wherein:
each channel has a planar bottom extending between planar sidewalls with a radius of curvature formed between the sidewalls and the bottom;
the at least two intermediate channels form an area therebetween;
each transition area includes a bottom ramp between the respective planar bottoms and a side ramp between the respective planar sidewalls; and
the first substrate is formed of collagen having a porosity selected to allow diffusion of components, the components being selected from the group consisting of: oxygen; carbon dioxide;
proteins; carbohydrates; fats; drugs; and combinations thereof.

14. The device of claim 13 , further comprising a maximum distance between the at least two intermediate channels does not exceed a maximum diffusion distance of oxygen and nutrients for cells, wherein the area includes cells derived from stem cells or from an organ selected from the group consisting of heart, liver, pancreas, intestine, brain, kidney, reproductive tissue, lung, muscle and bone marrow.

15. The device of claim 13 , wherein the at least two intermediate channels are first and second pairs of intermediate channels, the input and output channels bifurcate into first and second smaller channels, the first smaller channels are in fluid communication with the first pair of intermediate channels, and the second smaller channels are in fluid communication with the second pair of intermediate channels.

16. The device of claim 13 , wherein a bottom of the at least two intermediate channels is relatively higher than a bottom of the at least one input channel and the at least one output channel.

17. The artificial vasculature layer of claim 5 , wherein the areas are hexagonal.

18. The artificial vasculature layer of claim 3 , wherein the first fillets, the ramp, and the elongated fillet have different parameters that are determined by an iterative computational fluid dynamics (CFD) analysis to minimize shear stress concentrations, flow separation, stasis and turbulence.

Assignees

• Hoganson David M
• Pryor Howard I
• Spool Ira
• Vacanti Joseph P
• Borenstein Jeffrey T
• Massachusetts Gen Hospital
• The Charles Stark Draper Laboratory

Inventors

• Hoganson David M
• Pryor Howard I
• Spool Ira
• Vacanti Joseph P
• Borenstein Jeffrey T

Classifications

• A61F2/04

  Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts (A61F2/18, A61F2/20 take precedence; instruments specially adapted for placement or removal of stents or stent-grafts A61F2/95) · CPC title

• A61F2002/068

  Modifying the blood flow model, e.g. by diffuser or deflector · CPC title

• A61F2/06

  Blood vessels · CPC title

• A61F2/062 Primary

  Apparatus for the production of blood vessels made from natural tissue or with layers of living cells · CPC title

• G01N33/5008

  for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics · CPC title